The following article originally appeared in FiercePharma and was written by Arlene Weintraub Why did healthcare workers in California and Alabama have to return trays of Pfizer’s COVID-19 vaccine after discovering they were stored at temperatures that were colder than recommended? Does each vial of the vaccine contain more than the expected five doses, and if so, can those be used to meet the high demand for the shot? Those were some of the questions U.S. government officials addressed yesterday. Operation Warp Speed co-leader Gen. Gustave Perna kicked off a press conference
Read MoreThe following article originally appeared in FiercePharma and was written by Eric Sagonowsky The U.K.’s monumental approval for Pfizer and BioNTech’s COVID-19 vaccine turned heads worldwide, but one of the leading voices in the U.S. pandemic response argues the country’s regulators acted too quickly. “If you go quickly and you do it superficially, people are not going to want to get vaccinated,” NIAID director Anthony Fauci told Fox News. “We have the gold standard of a regulatory approach with the FDA.” The U.K.’s Medicines and Healthcare Products Regulatory Authority (MHRA) “did not do
Read MoreThe following article originally appeared in FiercePharma and was written by Arlene Weintraub With Moderna and Pfizer both reporting sky-high response rates to their COVID-19 vaccines, the pressure is on federal health officials to ensure a rapid—but smooth—rollout. Wednesday, they unveiled a detailed timeline that provides some clues about when most Americans can expect to be vaccinated. High-priority populations such as healthcare workers and nursing home residents could obtain COVID-19 vaccines in December, Department of Health and Human Services Secretary Alex Azar said in a press conference. Anthony Fauci, M.D., director of
Read More